Active — Not RecruitingNot Applicable

Physician Clinical Trial Policy (CTP) Neurological Ischemia Lower Extremity Pain and Swelling

1,000 participantsStarted 2012-03

Plain-language summary

Physician Clinical Trial Policy (CTP) to evaluate the efficacy treatment of lower extremity pathologies derived from neurological ischemia disorders using the combination of Monochromatic Infrared Photo Energy (MIRE) and Transcutaneous Electrical Nerve Stimulation (TENS) therapies.

Who can participate

Age range25 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * In the investigator's judgment, a high probability of 5 year survival and compliance with the study visit schedule. Ability to comprehend and sign an informed consent document prior to study enrollment. Exclusion Criteria: * Any other excluding factors that, according to the investigator's judgment, would preclude enrollment in the study.

What they're measuring

Primary Outcome: Scientific record of treatment success or failure

Timeframe: 5 years

Trial details

NCT IDNCT01979367

SponsorAmerican Association of Sensory Electrodiagnostic Medicine

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2027-01

View on ClinicalTrials.gov More Lower Extremity Swelling Acute trials